Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2004
11/04/2004US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004US20040220201 Tyrosine kinase inhibitors
11/04/2004US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004US20040220195 Antibiotic P175-A and semisynthetic derivatives thereof
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
11/04/2004US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004US20040220177 Anticancer agents
11/04/2004US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004US20040220170 analgesics; reduction of pain
11/04/2004US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004CA2523062A1 5-hydroxyindoles with n-oxide groups and use thereof as a phosphodiesterase 4 inhibitor
11/04/2004CA2523048A1 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents
11/04/2004CA2522803A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists
11/04/2004CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004CA2522536A1 Five-membered heterocyclic derivative
11/04/2004CA2518839A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
11/03/2004EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/03/2004EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
11/03/2004EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004EP1472226A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
11/03/2004EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004EP1472223A1 Gamma secretase inhibitors
11/03/2004EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004EP1471916A2 Treatment of rheumatoid arthritis using imatinie
11/03/2004EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004EP1471911A1 Novel crystalline forms of gatifloxacin
11/03/2004EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004EP1471786A1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
11/03/2004EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004EP1114117B1 Electrochromic device with a yellow filter
11/03/2004EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof
11/03/2004CN1543461A Melanocortin receptor ligands
11/03/2004CN1543460A Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
11/03/2004CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004CN1543455A 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
11/03/2004CN1543346A Novel compounds
11/03/2004CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004CN1173972C Azaring-ether derivatives and their use as nicotinic ach receptor modulators
11/03/2004CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives
11/03/2004CN1173970C Tetrahydroquinoline derivatives as glycine antagonists
11/03/2004CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/03/2004CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004CN1173950C 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation
11/03/2004CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/02/2004US6812344 1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004US6812231 Inhibiting activated blood-coagulation factor x
11/02/2004US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004US6812225 Pyschological disorders; antidepressants
11/02/2004CA2320676C Process and intermediates for the preparation of aminotriazine derivatives
11/02/2004CA2315614C Pyrazoles
11/02/2004CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
10/2004
10/28/2004WO2004092196A2 Tie-2 modulators and methods of use
10/28/2004WO2004092168A1 Cgrp receptor antagonists
10/28/2004WO2004092166A2 Cgrp receptor antagonists
10/28/2004WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004WO2004092158A1 Carboxamide derivatives as anti-diabetic agents
10/28/2004WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004WO2004092144A2 Quinazoline compounds useful as p38 kinase inhibitors
10/28/2004WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/28/2004WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004WO2004091542A2 Nitrogen containing integrin targeting compounds
10/28/2004WO2004091518A2 Cxcr4 chemokine receptor binding compounds
10/28/2004WO2004091514A2 Cgrp receptor antagonists
10/28/2004WO2004091485A2 Aminoquinoline compounds
10/28/2004WO2004091480A2 Tie-2 modulators and methods of use
10/28/2004WO2004080461A3 Stable pharmaceutical compositions of desloratadine